UBS Group Cuts Colgate-Palmolive (NYSE:CL) Price Target to $100.00

Colgate-Palmolive (NYSE:CL) had its price objective cut by stock analysts at UBS Group from $104.00 to $100.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. UBS Group’s target price points to a potential upside of 15.50% from the stock’s current price.

Several other research firms have also weighed in on CL. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Stifel Nicolaus reduced their target price on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating on the stock in a report on Monday. Raymond James reiterated an “outperform” rating and set a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a report on Monday. Morgan Stanley dropped their price target on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday. Finally, TD Cowen dropped their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $101.47.

Colgate-Palmolive Trading Down 0.1 %

Shares of NYSE:CL traded down $0.12 during midday trading on Monday, hitting $86.58. The company had a trading volume of 2,854,308 shares, compared to its average volume of 5,240,347. Colgate-Palmolive has a 12 month low of $82.68 and a 12 month high of $109.30. The company has a current ratio of 0.41, a quick ratio of 0.26 and a debt-to-equity ratio of 9.46. The stock has a market cap of $70.74 billion, a price-to-earnings ratio of 24.63, a PEG ratio of 3.61 and a beta of 0.44. The firm has a fifty day simple moving average of $91.35 and a 200 day simple moving average of $97.15.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the company posted $0.87 EPS. On average, analysts predict that Colgate-Palmolive will post 3.74 EPS for the current year.

Insider Transactions at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.37% of the company’s stock.

Institutional Investors Weigh In On Colgate-Palmolive

A number of institutional investors have recently made changes to their positions in the company. Union Bancaire Privee UBP SA bought a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $32,000. Hager Investment Management Services LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $36,000. Reston Wealth Management LLC bought a new stake in shares of Colgate-Palmolive in the third quarter valued at approximately $42,000. Roxbury Financial LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $43,000. Finally, Synergy Asset Management LLC bought a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $49,000. Institutional investors own 80.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.